EZH2 and hepatocellular carcinoma: Moreover, HDAC10 was found to recruit EZH2 enabling modification of the CXCL10 promoter region H3K27me3, producing CXCL10 transcriptional repression and therefore inhibiting NK cell migration and infiltration towards HCC (129).